The Reason We’re Here

Nohla’s differentiated universal donor product has been used to treat over 115 patients to date with the goal of providing meaningful treatments to those who have limited options. These patients are the reason we are here. For more information on our products or our ongoing clinical trials, we invite you to visit the Our Products section of our web site.

Gregg Gordon

Gregg Gordon had always been perfectly healthy before he was diagnosed with leukemia.

The father of two noticed bumps under his chin, and after visiting several doctors he was told that he needed to act quickly starting treatment.

A bone marrow transplant was presented as the best treatment option, but a matching donor could not be found among his family or in the donor registry. This was a significant setback for Gordon and his family, but with the aid of his referring physician he found out about the life-saving cord blood transplantation research being conducted by Dr. Delaney at Fred Hutchinson Cancer Research Center.

Travelling from his home in New York, Gordon went to Seattle to receive a double cord blood transplant with the addition of off the shelf expanded cord blood cells in Dr. Delaney’s clinical trial. The treatment that Gordon received saved his life. He and his family remain grateful to the researchers who made the expanded cord blood transplant possible.

Crystal Day

Cord transplants and cell therapy depend on mothers donating their baby’s umbilical cord. See how one mother’s donation saved Crystal Day’s life.